Central hypotensive effects of neuropeptide y are modulated by endothelial nitric oxide synthase after activation by ribosomal protein S6 kinase

British Journal of Pharmacology

Volumn 167, Issue 5, 2012, Pages 1148-1160

  Cheng, Pei Wen ^a   Wu, Alexander T H ^b   Lu, Pei Jung ^c   Yang, Ya Chun ^a   Ho, Wen Yu ^d   Lin, Hui Ching ^e   Hsiao, Michael ^f   Tseng, Ching Jiunn ^a,e,g,h  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d ZUOYING ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^e NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^f GENOMICS RESEARCH CENTER   (Taiwan)

^g NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^h NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

extracellular signal regulated kinases1 2; neuropeptide Y; nitric oxide; nucleus tractus solitarii; ribosomal protein S6 kinase

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEURONAL NITRIC OXIDE SYNTHASE; NEUROPEPTIDE Y; NEUROPEPTIDE Y1 RECEPTOR; NITRIC OXIDE SYNTHASE INHIBITOR; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; S6 KINASE; SERINE; URETHAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEART RATE; IMMUNOHISTOCHEMISTRY; MALE; MICROINJECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; SOLITARY TRACT NUCLEUS;

ANIMALS; BLOOD PRESSURE; CALCIUM; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HEART RATE; HYPOTENSION; MALE; NEUROPEPTIDE Y; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PROTEIN KINASE C; RATS; RATS, INBRED WKY; RECEPTORS, NEUROPEPTIDE Y; RIBOSOMAL PROTEIN S6 KINASES; SOLITARY NUCLEUS;

EID: 84867315467     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.02077.x     Document Type: Article

References (35)

1. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR, (1995). PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270: 27489-27494.
2. Alexander SP, Mathie A, Peters JA, (2011). Guide to Receptors and Channels (GRAC), 5th edition. Br J Pharmacol 164 (Suppl. 1): S1-324.
3. Bitran M, Tapia W, Eugenin E, Orio P, Boric MP, (1999). Neuropeptide Y induced inhibition of noradrenaline release in rat hypothalamus: role of receptor subtype and nitric oxide. Brain Res 851: 87-93. (Pubitemid 30038132)
4. Blomqvist AG, Herzog H, (1997). Y-receptor subtypes-how many more? Trends Neurosci 20: 294-298. (Pubitemid 27348738)
5. Cheng P-W, Lu P-J, Chen S-R, Ho W-Y, Cheng W-H, Hong L-Z, et al,. (2011). Central nicotinic acetylcholine receptor involved in Ca2+-calmodulin- endothelial nitric oxide synthase pathway modulated hypotensive effects. Br J Pharmacol 163: 1203-1213.
6. Dumont Y, Jacques D, Bouchard P, Quirion R, (1998). Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains. J Comp Neurol 402: 372-384. (Pubitemid 28541685)
7. Fetissov SO, Xu ZQ, Byrne LC, Hassani H, Ernfors P, Hokfelt T, (2003). Neuropeptide Y targets in the hypothalamus: nitric oxide synthesizing neurones express Y1 receptor. J Neuroendocrinol 15: 754-760. (Pubitemid 36874372)
8. Fisher TL, Blenis J, (1996). Evidence for two catalytically active kinase domains in pp90rsk. Mol Cell Biol 16: 1212-1219.
9. Fleming I, Fisslthaler B, Dimmeler S, Kemp BE, Busse R, (2001). Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity. Circ Res 88: E68-E75.
10. Gerald C, Walker MW, Criscione L, Gustafson EL, Batzl-Hartmann C, Smith KE, et al,. (1996). A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 382: 168-171. (Pubitemid 26242883)
11. Gur G, Bonfil D, Safarian H, Naor Z, Yaron Z, (2002). Pituitary adenylate cyclase activating polypeptide and neuropeptide Y regulation of gonadotropin subunit gene expression in tilapia: role of PKC, PKA and ERK. Neuroendocrinology 75: 164-174. (Pubitemid 34253072)
12. Hansel DE, Eipper BA, Ronnett GV, (2001). Neuropeptide Y functions as a neuroproliferative factor. Nature 410: 940-944. (Pubitemid 32335840)
13. Ho WY, Lu PJ, Hsiao M, Hwang HR, Tseng YC, Yen MH, et al,. (2008). Adenosine modulates cardiovascular functions through activation of extracellular signal-regulated kinases 1 and 2 and endothelial nitric oxide synthase in the nucleus tractus solitarii of rats. Circulation 117: 773-780. (Pubitemid 351640678)
14. Huang HN, Lu PJ, Lo WC, Lin CH, Hsiao M, Tseng CJ, (2004). In situ Akt phosphorylation in the nucleus tractus solitarii is involved in central control of blood pressure and heart rate. Circulation 110: 2476-2483. (Pubitemid 39407356)
15. Jin HK, Bae JS, Furuya S, Carter JE, (2009). Amyloid beta-derived neuroplasticity in bone marrow-derived mesenchymal stem cells is mediated by NPY and 5-HT2B receptors via ERK1/2 signalling pathways. Cell Prolif 42: 571-586.
16. Kask A, Harro J, von Horsten S, Redrobe JP, Dumont Y, Quirion R, (2002). The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci Biobehav Rev 26: 259-283. (Pubitemid 34555409)
17. Luquet S, Perez FA, Hnasko TS, Palmiter RD, (2005). NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science 310: 683-685. (Pubitemid 41528162)
18. Mahaut S, Dumont Y, Fournier A, Quirion R, Moyse E, (2010). Neuropeptide Y receptor subtypes in the dorsal vagal complex under acute feeding adaptation in the adult rat. Neuropeptides 44: 77-86.
19. McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
20. Michalkiewicz M, Zhao G, Jia Z, Michalkiewicz T, Racadio MJ, (2005). Central neuropeptide Y signaling ameliorates N(omega)-nitro-L-arginine methyl ester hypertension in the rat through a Y1 receptor mechanism. Hypertension 45: 780-785. (Pubitemid 40418381)
21. Michel MC, Beck-Sickinger A, Cox H, Doods HN, Herzog H, Larhammar D, et al,. (1998). XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 50: 143-150. (Pubitemid 28158845)
22. Mohr S, McCormick TS, Lapetina EG, (1998). Macrophages resistant to endogenously generated nitric oxide-mediated apoptosis are hypersensitive to exogenously added nitric oxide donors: dichotomous apoptotic response independent of caspase 3 and reversal by the mitogen-activated protein kinase kinase (MEK) inhibitor PD 098059. Proc Natl Acad Sci USA 95: 5045-5050.
23. Moleda L, Trebicka J, Dietrich P, Gäbele E, Hellerbrand C, Straub RH, et al,. (2011). Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction. Gut 60: 1122-1132.
24. Mullins DE, Zhang X, Hawes BE, (2002). Activation of extracellular signal regulated protein kinase by neuropeptide Y and pancreatic polypeptide in CHO cells expressing the NPY Y(1), Y(2), Y(4) and Y(5) receptor subtypes. Regul Pept 105: 65-73. (Pubitemid 34164384)
25. Nakata S, Tsutsui M, Shimokawa H, Tamura M, Tasaki H, Morishita T, et al,. (2005). Vascular neuronal NO synthase is selectively upregulated by platelet-derived growth factor: involvement of the MEK/ERK pathway. Arterioscler Thromb Vasc Biol 25: 2502-2508. (Pubitemid 43732270)
26. Robich MP, Matyal R, Chu LM, Feng J, Xu SH, Laham RJ, et al,. (2010). Effects of neuropeptide Y on collateral development in a swine model of chronic myocardial ischemia. J Mol Cell Cardiol 49: 1022-1030.
27. Rudolf K, Eberlein W, Engel W, Wieland HA, Willim KD, Entzeroth M, et al,. (1994). The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226. Eur J Pharmacol 271: R11-R13.
28. Tai MH, Hsiao M, Chan JY, Lo WC, Wang FS, Liu GS, et al,. (2004). Gene delivery of endothelial nitric oxide synthase into nucleus tractus solitarii induces biphasic response in cardiovascular functions of hypertensive rats. Am J Hypertens 17: 63-70. (Pubitemid 38064762)
29. Tatemoto K, Carlquist M, Mutt V, (1982). Neuropeptide Y-a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296: 659-660. (Pubitemid 12089070)
30. Tseng CJ, Mosqueda-Garcia R, Appalsamy M, Robertson D, (1989). Cardiovascular effects of neuropeptide Y in rat brainstem nuclei. Circ Res 64: 55-61. (Pubitemid 19028503)
31. Tseng CJ, Liu HY, Lin HC, Ger LP, Tung CS, Yen MH, (1996). Cardiovascular effects of nitric oxide in the brain stem nuclei of rats. Hypertension 27: 36-42.
32. Vlahos CJ, Matter WF, Hui KY, Brown RF, (1994). A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269: 5241-5248.
33. Waki H, Murphy D, Yao ST, Kasparov S, Paton JF, (2006). Endothelial NO synthase activity in nucleus tractus solitarii contributes to hypertension in spontaneously hypertensive rats. Hypertension 48: 644-650. (Pubitemid 44843867)
34. Wolak ML, DeJoseph MR, Cator AD, Mokashi AS, Brownfield MS, Urban JH, (2003). Comparative distribution of neuropeptide Y Y1 and Y5 receptors in the rat brain by using immunohistochemistry. J Comp Neurol 464: 285-311. (Pubitemid 36992215)
35. Yang SN, Narvaez JA, Bjelke B, Agnati LF, Fuxe K, (1993). Microinjections of subpicomolar amounts of NPY(13-36) into the nucleus tractus solitarius of the rat counteract the vasodepressor responses of NPY(1-36) and of a NPY Y1 receptor agonist. Brain Res 621: 126-132. (Pubitemid 23242170)